InvestSMART

Holista Colltech Limited (ASX:HCT)

ALERT: Price-sensitive ASX Announcement for HCT
Current share price for HCT : $0.043 -0.02 (-31.75%)+
Announcement
Release
22 Apr 2026 2:55PM
Price at Release
$0.063
Full Release
download
Summary
Holista Colltech Limited announced that the Supreme Court of Western Australia ruled in favor of The ProImmune Company, LLC, granting a summary judgment to enforce a US court's decision awarding ProImmune over $2 million due to breaches in distribution agreements for the Immune Formulation 200® product. Holista's cross-claim of misleading conduct was dismissed for lack of sufficient evidence. Following the judgment, Holista agreed to a settlement amount of $1.8 million, a reduction from the judgment debt, to resolve the case entirely.
Key Points
  • Supreme Court of Western Australia ruled in favor of ProImmune.
  • Judgment amounting to US$2,063,141.05 was enforced.
  • Holista's cross-claim was dismissed as insufficient.
  • Settlement agreed at US$1,800,000.
  • Initial payment of US$1,000,000 followed by US$800,000 before July 2026.
  • Settlement considered in the best interest of Holista and its shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.